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Background: The intervention reported in this paper was a follow up to an empirical study conducted in Malawi
with the aim of assessing trial participants’ understanding of randomisation, double-blinding and placebo use. In
the empirical study, the majority of respondents (61.1%; n=124) obtained low scores (lower than 75%) on
understanding of all three concepts under study. Based on these findings, an intervention based on a narrative
which included all three concepts and their personal implications was designed. The narrative used daily examples
from the field of Agriculture because Malawi has an agro-based economy.
Methods: The intervention was tested using a sample of 36 women who had been identified as low scorers during
the empirical study. The 36 low scorers were randomly assigned to control (n=18) and intervention arms (n=18).
The control arm went through a session in which they were provided with standard informed consent information
for the microbicide trial. The intervention arm went through a session in which they were provided with a narrative
in ChiChewa, the local language, with the assistance of a power point presentation which included pictures as well
as discussions on justification and personal implications of the concepts under study.
Results: The findings on the efficacy of the intervention suggest that the 3 scientific concepts and their personal
implications can be understood by low literacy populations using simple language and everyday local examples.
The findings also suggest that the intervention positively impacted on understanding of trial procedures under
study, as 13 of the 18 women in the intervention arm, obtained high scores (above 75%) during the post
intervention assessment and none of the 18 in the control arm obtained a high score. Using Fischer’s exact test, it
was confirmed that the effect of the intervention on understanding of the three procedures was statistically
significant (p=0.0001).
Conclusions: Potential trial participants can be assisted to understand key clinical trial procedures, their justification
and personal implications by using innovative tailored local narratives.
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Several authors have reported or discussed some difficul-
ties that research participants face in understanding cli-
nical trial concepts. Various studies have also confirmed
that trial participants have problems understanding the
differences between research and routine care [1-8].
There is general agreement that the trial concepts of
randomization, double blinding and placebo are difficult
to explain to study participants since they are part of the
scientific language that low literacy populations are not
familiar with [3-8]. Limited understanding of trial proce-
dures suggests that what is often termed informed con-
sent may not be adequately informed and goes against
the principle of respect for persons which requires that
individuals understand the information they are pro-
vided with before making decisions on participating in a
trial. Limited understanding may also be a sign that the
kind of information being received by trial participants,
as well as the methods used in providing the information
to study participants, may not be optimal.
In order to try and address the problem of limited
understanding, various studies have been conducted glo-
bally to test interventions aimed at improving trial partici-
pants’ understanding of research participation, including
clinical trial procedures. Some studies have attempted to
introduce flexibility in the process of information disclo-
sure in order to suit the information needs of the potential
trial participants [9-11]. Some have considered supple-
menting informed consent information using video or
computer technology [12-14]. In contrast, others have
looked at the usefulness of educational booklets as a way
of supplementing information while other studies have
considered the provision of information in a modular and
hierarchic approach [14-16]. Other studies have sought to
assess the usefulness of trial specific tailored information
while others have focused on reducing the reading levels
of informed consent documents. Some have considered
the use of simplified informed consent forms [17-20].
Realizing that children also take part in trials and have
unique information requirements, one specific study has
looked at the development of informed consent docu-
ments for children [21]. In recognition of the fact that
much research is conducted among low literacy popula-
tions globally, some studies have tested interventions
aimed specifically at addressing information disclosure in
low literacy populations [22-24]. One study tested the use
of a decision aid kit in informed consent while another
tested an intervention aimed at improving understanding
of placebo use [25,26].
Reported interventions have focused on different areas
of emphasis ranging from modifying the informed consent
process, supplementing the informed consent information
to simplifying the information through lowering reading
level or simplification of the informed consent forms.Review of reports on interventions confirms that some of
the more effective interventions were based on the follo-
wing characteristics: better organized processes, shorter
and more readable informed consent documents, simplified
and illustrated formats, and corrected feedback [27-29].
The reviewers point out the challenge of distinguishing
between understanding and recall in some of the studies
and suggest the use of various interactive techniques in
efforts to improve understanding. These reviews concluded
that efforts to improve understanding through the use of
multimedia and enhanced informed consent forms have
had only limited success. The limited success may be attri-
buted to the fact that the so called video or computer pro-
grammes may just be a repetition of the same information
that is provided through the informed consent form with-
out much change.
A critical review of previous interventions revealed vari-
ous weaknesses which could have reduced the impact of
some of the interventions. By looking critically at the
information that was disclosed through some interven-
tions, it was evident that some interventions assumed that
people know what research entails [14]. It was clear that
some interventions assume that people are familiar with
clinical trial procedures [9]. Some interventions did not
assist in making individuals aware of the trial procedures
and their purposes [17]. It was also evident that some
interventions did not deal adequately with the personal
implications of research participation and of specific trial
procedures [17]. These observations are supported by the
review of interventions which concluded that some of the
interventions that are developed to improve understan-
ding are poorly thought out and are merely a repetition of
the information from informed consent documents using
different media [28].
The intervention reported in this paper was developed
in response to findings from an empirical study (under
review) that identified some respondents who scored
low (<75%) on measures of key elements of understand-
ing of clinical trials. The intervention had been antici-
pated even before initiating the study because several
studies conducted elsewhere found low levels of under-
standing among study participants [3-8]. It would have
been unethical to ignore this problem after identifying it
empirically. The researchers were also convinced by
available literature suggesting the efficacy of well
thought out interventions [10,21,22,30].
Objectives of the intervention study
The intervention study was based on the premise that po-
tential trial participants can understand trial procedures
and their personal implications if the explanations that are
provided to potential participants about the procedures in-
clude details on how the procedure will be implemented,
and the justification and personal implications of those
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was therefore to design, implement and test the usefulness
of a pilot intervention aimed at improving understanding
of randomisation, double-blinding and placebo use and
their personal implications.Methods
The intervention designed as part of this study was based
on the nature of data yielded by our empirical study
(under review) conducted in Lilongwe and Blantyre at two
sites of a multi-country microbicide trial between 2008
and 2009. The empirical assessment study assessed trial
participants’ understanding of randomisation, double-
blinding and placebo use and their personal implications.
In the empirical study, the majority of respondents (61.1%;
n=124) obtained low scores (lower than 75%) on under-
standing of all three concepts under study. The interven-
tion reported in this paper used everyday examples in
explaining clinical trial procedures and their implications.
African cultures are generally well known for story telling
as a way of educating individuals [31,32]. Stories with
some meaning are often told as a way of ensuring that
individuals understand a particular issue. The intervention
did not make any assumptions about pre-existing know-
ledge and it was based on the review of existing interven-
tions and studies aimed at testing some related
interventions [9,11,12,14-17,19,20,29].
The intervention was mainly based on Faden and
Beauchamp’s psychosocial schema, which views
informed consent as being made up of three sequential
behavioural steps: (a) reception, (b) comprehension and
(c) utilisation of the comprehended information in
reaching a decision whether or not to participate in a
study [33]. The schema postulates that for consent to be
informed, a prospective trial participant has to go
through the three steps. The intervention also borrowed
from the Meerwein model of information processing
[34]. Meerwein's model defines three main dimensions
of the informing process, namely (a) the information
itself, (b) the emotional dimension concerned with
rapport between the researcher and the participant, and
(c) the interactional dimension which is concerned with
the capacity and willingness of the research staff to per-
ceive and discuss emotional needs, concerns and com-
plaints of trial participants and to deal with these.
The main components of the intervention consisted of
a PowerPoint presentation which included a mix of the
following approaches:
 A hierarchical and modular approach to providing
information. This entails providing information in
manageable sections. The information becomes
more complex as the presentation proceeds [16]. Use of vignettes in explaining the trial concepts and
research [35].
 Colourful pictures were included in the presentation
to supplement written information and the
discussions about microbicides and the trial
[9,12,24]. Purpose, justification and implications of
research participation and trial procedures were also
included [4].
 Asking patients to repeat in their own words or
explain to others [35].
 Use of other appropriate ways of ensuring personal
understanding, including inviting research
participants to discuss with other participants
[36,37].
 Use of a neutral team of intervention staff distinct
from the research team in group discussions with
trial participants. These were persons who had been
trained to teach potential participants about the key
methodologic aspects of research and who had
experience in research [38].
The intervention was implemented in the form of a nar-
rative which was given in ChiChewa, the local language,
with the assistance of a PowerPoint presentation. Figures 1,
2, 3 below show some of the slides that were used in the
intervention. The intervention was based on a story about
a company which intended to test a new fertilizer in an
area (Ntcheu) where farmers were experiencing very low
potato yields. Ntcheu is well known throughout Malawi
for Irish potato production. Using the fertilizer story, the
concepts of research, randomisation, double-blinding and
placebo use were illustrated including the reasons why re-
search is necessary and why these procedures were
employed as well as the personal implications of these
procedures to the farmers in Ntcheu. In the narrative, the
farmers were given some eligibility criteria (including hav-
ing one acre plot and willingness to participate). The farm-
ers were randomised by picking small pieces of paper
from a hat that were numbered from 1–100. These num-
bers would determine the “fertiliser bag” that each farmer
would take home. There were 100 bags all of the same
colour and 50 of them contained the test product (the fer-
tiliser) while 50 contained “some material” which looked
exactly like the test fertiliser but did not have any of the
chemicals in the test fertiliser (placebo). The farmers and
the agriculture extension workers were both not aware of
which study arms farmers had been assigned to since the
test product and the placebo had been packed in bags
which looked similar. The intervention covered the appli-
cation of the procedures as well as the interpretation of
the findings from the fertiliser study. This was aimed at
ensuring that the intervention promoted a fuller under-
standing of research and trial procedures. After narrating
the story, the presenter then related the Irish potato
Figure 1 Slide showing the problem of low potato yields in Ntcheu area.
Figure 2 Slide showing results from different potato plots.
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Figure 3 Slide linking clinical trials to the medicines that are
available in pharmacies, hospitals and stores.
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microbicide clinical trial, including the trial concepts
under study (as well as their justification and personal
implications).
The intervention was implemented on 20th August 2009
at the Blantyre site only for logistical and budgetary reasons.
All follow-up activities of the microbicide trial had already
come to an end and participants had been informed about
the findings from the microbicide study in March 2009.
This therefore meant that the intervention did not in any
way impact on the microbicide study since the microbicide
study activities had already come to an end. The microbi-
cide study had established that the two products which
were being tested were not effective in protecting women
against HIV infection [39]. The intervention was approved
by the principal investigator at the Blantyre Site after being
briefed about the findings from the empirical study that
had tested understanding of the three trial concepts. The
principal investigator then informed the study team mem-
bers about the impending intervention and requested them
to support the intervention by providing space and logis-
tical support.
A list of the low scorers from the Blantyre site was
provided to the microbicide study staff so that they
could assist with the tracing of the women who had par-
ticipated in the empirical study. From a list of 77 partici-
pants who obtained low scores at the Blantyre site,
current contact details could only be found for 63 parti-
cipants who were still based in Blantyre. It was noted
that 56 of the 63 participants who were identified were
based in Manyowe and Manase areas. A decision was
therefore made to follow-up only the 56 participants
from Manyowe and Manase areas. Staff who were
employed as field tracers at the microbicide trial site
were requested to visit the homes of all 56 participants.
It is important to note that during the empirical study,
the women had given permission to be re-contacted forthe purpose of continuing with the intervention. The
researcher in the current study offered transport as well
as other logistical support to the field tracers. The field
tracers found 38 women at their homes and invited
them to visit the study site for the intervention study.
For the remaining 18 who were not available, the field
tracers left messages inviting them to visit the study site
at 8:00am on Thursday August 20, 2009.
On Thursday 20th August 2009, by 8:30am there were
39 women present and a decision was made to precede
with the study activities. All 39 women had scored less
than 75% during the initial assessment. Informed con-
sent was sought from all 39 women after disclosure of
information by a study team member. The information
which was provided included reminding them about the
microbicide study, the empirical study on understanding
of procedures, and then requesting their consent for the
intervention study. Three women indicated that they
could not spend more than one hour at the site as they
had to collect their children from school and were
accordingly excluded from the study activities and reim-
bursed for transport expenses. Three women arrived
more than 25 minutes after the two sessions had already
begun. The three were not invited to join as they would
have affected the flow of activities. They were, however,
offered some refreshments and reimbursement for trans-
port, and were given the opportunity to meet the micro-
bicide study nurses for any issues that they might want
to discuss with them.
The remaining 36 women indicated verbally that they
were consenting to continue with their participation
in the study and were prepared to go through all the
remaining activities of the current study (Note that
at this time, the microbicide study had already been
terminated). The 36 women were accordingly rando-
mised into two groups using small papers numbered
from 1–36. All those who picked odd numbers were
assigned to the intervention arm and those who picked
even numbers were assigned to the non-intervention
arm which was going to receive standard microbicide
trial informed consent information.
A trial nurse responsible for obtaining informed con-
sent was requested to present standard informed con-
sent information on the microbicide study to the 18
women in the non-intervention group, in addition to
health information on cervical cancer, and was advised
to allow the women to ask questions. Our ethical con-
cern here was to make the non-intervention group ‘more
than placebo’ by imparting some useful women’s health
information unrelated to the information presented in
the intervention arm.
The two sessions began at the same time and the non-
intervention arm session ended about 30 minutes earlier
than the intervention session. The women were then
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basis. There were two research assistants administering the
questionnaire and the two groups were kept in separate
rooms and there was one study team member who coordi-
nated the movement of the women from the two sessions
to the separate rooms that had been assigned for the post-
intervention interviews. Each interview took on average 15
to 20 minutes since the post-intervention questionnaire
was shorter than the initial one (it only included questions
on the 3 concepts as well as their implications). Figure 4
diagrammatically illustrates the procedures that were fol-
lowed in the implementation of the pilot intervention in-
cluding decisions that had to be made at the various stages.
All participants were reimbursed for transport and all those
who were interviewed during or after lunch hour were pro-
vided with refreshments.Figure 4 Illustration of pilot intervention procedures.Data from the 36 pre-coded questionnaires was mana-
ged using SPSS version 10 after checking by the investiga-
tors for completeness and consistency. The quantitative
data was cleaned using the appropriate techniques includ-
ing double-checking and was analysed using frequencies,
percentages, means, standard deviations, cross tabulations,
group statistics, matched pair analysis and other statistical
tests such as independent sample tests, Chi-Square test
and Fischer’s exact test. Figures, percentages and tables
were used to summarise the data.
The following measures were taken to remove bias:
 Interviewers were blinded regarding the group the
individuals they were interviewing had participated
in. The 36 women were randomly assigned to the
two interviewers.
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unblinding of groups.
 Individuals involved in presenting the intervention
and the placebo programme did not participate in
the assessment or in the scoring – scoring was thus
independent and blinded.
 The intervention and second assessment were done
about eight months after the empirical study. This
could have assisted in eliminating the effects of
history and maturation of instrument.
The intervention was implemented in accordance with
the requirements of the Declaration of Helsinki. Permis-
sion was sought in writing and granted by the Principal
Investigators at the two sites before data collection for this
study. The study was reviewed and approved by two Re-
search Ethics Committees (RECs) at the University of
KwaZulu-Natal (Approval number HSS/0679/07D) and
the College of Medicine, University of Malawi respectively
(Approval P/02/08/612). Written informed consent was
sought and obtained from all the study participants after
purpose of the intervention as well as the procedures to
be followed during the intervention. Those who refused to
participate in the intervention for various reasons were
excluded (n=3). The women who participated in the study
were reimbursed for transport using the standard rate ap-
plicable at both sites. They were also provided with
refreshments in view of the additional time they had to
spend at the site.
Results
Demographic characteristics
There were 18 women in both the intervention and
non-intervention arms of the intervention study who
had been randomly assigned. The ages of the 36 women
were evenly distributed across the two groups. This dis-
tribution was roughly reflective of the distribution in theTable 1 Distribution of intervention phase participants by ag
Distribution
Age Freq Percent Non inter
20-25 11 30.6 33.3
26-30 11 30.6 33.3
31-35 11 30.6 27.8
36-40 3 8.3 5.6
Total 36 100.0 100
Distribution of participant
Standard 1-4 2 5.6 5.6
Standard 5-8 24 66.7 72
Form 1-4 10 27.8 22.2
Total 36 100.0 10sample of the empirical study sample (n=203). Table 1
shows the age distribution of the intervention sample.
The majority of women (24) had 5–8 years of school-
ing, followed by those who had 1–4 years of secondary
education (10). The distribution of the women by years
of schooling was evenly balanced across the two groups
and consistent with the distribution during the preced-
ing empirical phase of the study, showing the effective-
ness of the random sampling method that was adopted.
Table 1 also shows the distribution of the intervention
sample by years of schooling across the two groups. The
majority of the intervention participants had attended
up to eight years of primary education.
By the time of implementing the intervention, all
microbicide trial participants had already been
informed about the microbicide study arm they were
in. This was done during the time they were informed
about the microbicide study findings. Twenty three
(23) of the women who participated in the interven-
tion phase were from either of the two active product
arms of the microbicide trial, while 13 were from the
trial’s placebo arm. This distribution shows that the
random sampling strategy used in selecting partici-
pants for the intervention phase led to a balanced
sample. The intervention study sample included at
least one third from each of the three gel arms of the
microbicide study. Eight (8) of the 13 who were on
the placebo arm indicated that they felt cheated or
betrayed when they were informed about the arm
they were on during the study. This finding presented
some evidence of false confidence among the partici-
pants. It also showed that participants did not appre-
ciate the real possibility of being on placebo or the
unproven efficacy of the test product. All eight (8)
women reported that they felt betrayed as they
believed that they were using an active product which
would have protected them.e and level of education
by age
vention arm Intervention arm Cumulative %
% (6) 27.8% (5) 30.6
% (6) 27.8% (5) 61.1
% (5) 33.3% (6) 91.7
% (1) 11.1% (2) 100.0
% (18) 100% (18)
s by level of education
% (1) 5.6% (1) 5.6
.2 (13) 61.1% (11) 72.2
% (4) 33.3% (6) 100.0
0 (18) 100% (18)
Table 2 Mean and median scores by group before and after intervention
Before intervention
(n=36)
Non intervention group after intervention
(n=18)
Intervention group after intervention
(n=18)
Mean Median Mean Median Mean Median
Randomisation 78 75 78.42 90 92 100
Double-blinding 74.86 78.00 64.83 67 85.17 100
Placebo 56.11 60.00 78.67 83.0 91.61 100
Implications 42.92 44.00 58.17 55 74.11 78
Composite score 60.53 60.00 70.19 67 88.89 100
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In order to assess the effectiveness of the intervention,
the average scores for each concept were compared for
the two groups before and after the intervention. From
the findings in Table 2 below, it is evident that after the
intervention, the mean and median scores improved for
both groups on understanding of randomisation, placebo
use and personal implications. The fact that both groups
experienced increases in scores on understanding of cer-
tain concepts suggests the effect of some confounding
variables. The termination of the microbicide trial as
well as dissemination of the microbicide study results
could have served as confounders. The two factors could
have reinforced the fact that the microbicide trial was in-
deed a study and not a programme aimed at HIV pre-
vention. Study nurses reported that upon termination of
the microbicide study, they invited the trial participants
to bring back to the site any remaining gels, only to find
that some of them had shared the gels with their collea-
gues. The increased scores for the non-intervention arm
were however small compared to the increases evi-
denced by the intervention arm. This finding provides
some evidence for the short-term usefulness of the inter-
vention in improving understanding.Table 3 Distribution of composite scores before and after the
Distribution of scores be
Low score 0-49%






Distribution of scores a





percentage 13.9%Before the intervention, there were no differences in
terms of the distribution of scores between the interven-
tion group and the non-intervention group as shown in
Table 3 below. Table 3 confirms that before the implemen-
tation of the intervention, all 36 women were in the low
score category. Our results confirm that after the interven-
tion, 13 women in the intervention arm had moved to the
high score category of 75% and above as presented in
Table 3 below. In the intervention group, after the inter-
vention, no participants remained in the 0-50% score cat-
egory while five women remained in this category in the
non-intervention arm. This finding suggests the effective-
ness of the intervention in improving understanding.
Fischer’s exact test was used to confirm the effect of
the intervention on understanding of randomisation.
Interestingly, Fischer’s exact test revealed that the influ-
ence of the intervention on understanding of randomisa-
tion was not statistically significant (p=0 .075). To assess
the effect of the intervention on improving understand-
ing on placebo use, a p-value of 0.003 using Fischer’s
exact test was obtained. This p-value indicated that there
was a statistically significant relationship between the
intervention and improved understanding of placebo
use. Fifteen (15) of the 18 participants in theintervention
fore the intervention
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ing of placebo use, compared to only 6 on the non-
intervention arm. Cross-tabulation of intervention by
score on double-blinding also showed that the interven-
tion had a statistically significant effect on scores of
understanding of double-blinding. Thirteen women in
the intervention arm scored highly (75%+) as compared
to only 3 women in the non-intervention arm. A p-value
of p=.001 was obtained using both Pearson’s chi-square
and Fischer’s exact test. This p-value indicates that there
was a statistically significant relationship between the
intervention and improved scores on double-blinding.
The effect of the intervention on the understanding of
personal implications was also assessed. A p-value of
0.000 was obtained using Fischer’s exact test and Pear-
son’s chi square test. This p-value confirmed that the
intervention had a statistically significant impact on
improved understanding of personal implications of re-
search participation. Eleven (11) of the 18 women on the
intervention arm scored highly (75%+) on understanding
of personal implications in contrast to only one woman
on the non-intervention arm.
In an attempt to assess the impact of the intervention
on overall understanding of all four areas under study, the
independent variable (the intervention) was cross tabu-
lated with the composite score. Table 4 below indicates
that 13 of the participants in the intervention arm mana-
ged to obtain high scores, while no participant from the
non-intervention arm managed to score 75% and above. A
p-value of 0.0001 was obtained using both Pearson’s chi-
square test and Fischer’s exact test, signifying that there
was a statistically significant relationship between the
intervention and the improved composite scores obtained.
Matched pair analysis of the scores of the participants
in the intervention arm before and after the intervention
indicates that all participants experienced some signifi-
cant gains in scores except for one who experienced a
drop of 2% from 65% before the intervention to 63%
after the intervention. Nine of 18 respondents showed
very large gains of 20% and above, while 8 of the 18
respondents experienced some gains of between 10%
and 19%. Only one participant experienced a minimal
loss of 2% (Refer to Table 5).Table 4 Relationship between intervention and composite sco
Low scorer 0




TOTAL Total Count 23
Total % 63.9%Matched pair analysis of the scores of the participants
from the non-intervention group before and after the
intervention revealed that the majority of the partici-
pants scored lower during the second assessment.
Twelve of the 18 respondents experienced negative gains
ranging from −1 to as high as −28, and two respondents
did not experience any gain in their scores. This finding
confirms the suggestion that history and maturation of
instrument had very minimal bias on the scores since
the second assessment was done about 8 months after
the first assessment. The difference between the gains of
the intervention arms and those of the non-intervention
arm also confirms that the standard package that was
used for the non-intervention did not influence the
scores of the non-intervention arm in a significant way.
Interestingly, seven (7) of the 18 non-intervention
respondents experienced losses of 10% and above. Such
losses were classified as significant losses (10-19%) and
very significant (20% and above). Only two respondents
experienced significant gains of between 10-19% (Refer
to Table 6).
Group statistics and independent sample tests were
also calculated for the two groups. Table 7 below show
the group statistics on all the categories that were scored
after the intervention. Table 7 also shows that the mean
scores obtained by members from both groups before
the intervention were almost similar. After the interven-
tion, the mean and median values for the intervention
group were higher than those obtained by the non-
intervention group for all areas under study.
Independent sample tests were done before and after
the intervention to check on the usefulness of the inter-
vention at group level. P-values above 0.005 were obtained
for scores before the intervention, and p-values below
0.005 were obtained for all the four scores after the inter-
vention. The p-values before the intervention show that,
before the intervention, there were no significant differ-
ences between the two groups while those after the inter-
vention confirm that there were significant differences
between the groups. This finding is particularly important
as it shows that the samples were independent and that
the intervention had a positive effect on understanding of
all four areas under consideration in this study.re




















164 63 50 +13 Pos Significant
093 70 65 +15 Pos Significant
112 70 58 +12 Pos Significant
150 70 58 +12 Pos Significant
183 85 70 +12 Pos Significant
136 89 68 +13 Pos Significant
158 89 63 +13 Pos Significant
184 89 60 +29 Pos Very sig
191 89 60 +29 Pos Very sig
179 93 68 +25 Pos Very sig
083 96 70 +26 Pos Very sig
157 96 58 +38 Pos Very sig
198 96 40 +56 Pos Very sig
063 100 58 +42 Pos Very sig
202 100 50 +50 Pos Very sig
096 81 68 +13 Pos Significant
135 85 63 +22 Pos Very Sig
070 63 65 −2 Neg Minimal
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plementation of the intervention. The intervention was
presented in an environment that encouraged discus-
sion and the participants were free to interrupt the
























194 44 60Of interest were some of the comments that came
from participants during and after the intervention.
The following comments specifically shed more light
on the usefulness of the intervention in improving






















−28 Neg Very Significant
−7 Neg Minimal
−14 Neg Significant

















Non intervention 18 60.39 55.72 9.26 10.45 2.18 2.46
Intervention 18 60.67 92.22 7.93 15.55 1.87 3.67
Implications Non intervention 18 41.78 42.22 9.99 13.36 2.36 3.15
Intervention 18 44.06 84.67 16.40 12.36 3.87 2.91
Double-
blinding
Non intervention 18 54.44 44.50 20.36 34.14 4.80 8.05
Intervention 18 57.78 74.11 22.64 19.60 5.34 4.62
Placebo use Non intervention 18 74.83 65.72 20.43 21.81 4.81 5.14
Intervention 18 74.89 85.17 15.42 26.22 3.63 6.18
Randomisation Non intervention 18 79.33 64.61 12.19 29.17 2.87 6.88
Intervention 18 76.67 91.61 13.56 13.14 3.20 3.10
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supposed to buy the new fertilizer at a reduced price. If
the company was selling the fertilizer at K100, they
should sell it to the farmers at K50 because the
farmers would have assisted in the development of
the fertilizer.
The fifty farmers who got the test product benefitted
immensely through the improved yields. The company
was supposed to give the new fertiliser to the other fifty
so that they can benefit as well since they participated
in the research.
The above comments clearly show that these particu-
lar women had clearly realised that the farmers in
Ntcheu had been used as part of a study and the aim of
the study was the generation of new information that
could be used in establishing if the new fertilizer was ef-
fective. The issue of justice and benefit sharing by giving
the test product to the control arm in the event of suc-
cessful results has been an area of active debate in re-
search ethics recently. It was interesting that two of the
participants could justify claim to benefits in those ways.
The participants had clearly realised that, by participat-
ing in the research, they were going to assist others in
future, just as the farmers participated in the research
which eventually led to improvements in yields for the
whole nation.
The majority of the women were grateful to the
presenter for having presented the information in a way
which was easy to understand.
LLP7: On behalf of my friends, I am grateful to you for
your coming. To be frank we have learnt a lot from
this discussion about the Microbicide study. We have
been participating in the microbicide study. The wayyou explained it, was as if you were talking about a
new study. Your questions made us think about what
we went through during our participation in this study
and it will help us to remember this study forever. So,
we don’t take our participation in the discussion for
granted- we thank you so much!
The majority of women were very appreciative of the
microbicide study as they indicated that it had assisted
them in learning about their HIV status, and they were
assisted by the staff whenever they had health problems.
Discussion
The findings of this pilot intervention, which aimed at
testing the effectiveness of an intervention aimed at im-
proving understanding of the three concepts (random-
isation, double-blinding, placebo use) and their personal
implications, suggest that the intervention was effective
in improving understanding. The findings suggest that
understanding of trial concepts can be improved if
explained in clear and local terms. Women in both the
intervention and non-intervention arms were selected
because they had obtained low scores in the initial test
that was administered during the empirical study that
we conducted on trial participants understanding prior
to development and implementation of this intervention
(under review). After the intervention, the majority of
women on the intervention arm scored significantly
higher on the understanding of all four areas under
study (randomisation, double-blinding, placebo use and
their personal implications) compared to those in the
non-intervention arm.
The success of the intervention can be attributed to
various factors. Studies on previous intervention were
reviewed and points taken on weaknesses, strengths and
areas of improvement. All these were taken into
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which was tested in this study. The intervention was deliv-
ered in ChiChewa, which is the dominant language in Ma-
lawi. The use of local language in informed consent is
emphasised in earlier works and was aimed at ensuring
that the information disclosed would be meaningful to all
respondents, regardless of their educational level [24,40].
Throughout the intervention, layman’s language was used
in explaining the procedures and their justifications. As
suggested in an earlier work, examples were taken from
agriculture since Malawi is an agriculture-based country
and every individual is conversant with agriculture [35].
Adequate time was provided for the implementation of
the intervention. In this case, the aim was only to improve
understanding, unlike in many real clinical trial settings
where staff may be preoccupied with meeting accrual tar-
gets rather than enhancing understanding.
A hierarchical and modular approach to providing in-
formation was used. As recommended in literature, care
was taken to ensure that information was provided on
each concept to cover all three areas, namely proce-
dures, purpose, and personal implications [16]. The pro-
cedures were explained in the form of a story which was
interesting and easy to follow and relate to as suggested
by findings from a previous study [35]. In Malawian cul-
ture, as has been observed to be the case in the majority
of African cultures, folktales are used as a useful way of
passing important lessons to individuals [32]. Materials
were presented in a way which was easy to understand –
a PowerPoint presentation, which included colourful pic-
tures, was designed and used as a way of supplementing
the information about research, the microbicide study
and the procedures under study, as well as their implica-
tions. This study corroborates previous studies that have
reported that participants can find information meaning-
ful irrespective of their educational level [12,24,40,41].
Inclusion of purpose, justification and implications of
the research procedures and research participation was
specifically important. The intervention not only focused
on the three concepts but brought the three concepts
into context so as to make the information more mean-
ingful. Informed consent procedures are often tailored
towards mentioning procedures without necessarily de-
scribing the procedures in meaningful ways [4].
During the intervention, participants who had under-
stood the concepts were asked to repeat what they had
understood to the presenter or to their colleagues. Parti-
cipants were also allowed to discuss among themselves
during and after the intervention. These strategies have
been reported to be useful in improving understanding
[35,37].The intervention was presented by a staff mem-
ber from the Centre for Bioethics at the College of
Medicine. The presenter was not a member of the
microbicide trial research team at the site. During theimplementation of the intervention, the microbicide trial
staffs were not invited. This ensured that the women
would discuss issues freely during the intervention. The
presenter was familiar with the microbicide project and
had a lot of experience in clinical trial issues, including
key methodologic aspects of research. Research staff
knowledge and experience with research has been cited
as playing an important role in improving informed con-
sent [38]. The findings on the effectiveness of the inter-
vention are consistent with other findings which showed
that story-based interventions were useful as they facili-
tated understanding of concepts and procedures [21,23].
The effect of the intervention on recruitment and reten-
tion was not evaluated since the microbicide study had
already come to an end. It would have been interesting
to test the suggestion by others that provision of ad-
equate information may actually lead to greater under-
standing, which may ultimately lead to lower enrolment
rates through more ‘informed refusals’ [42].
During the planning of the intervention, it had been
planned and agreed that the intervention would be
introduced to the 18 women in the non-intervention
arm if it had been found to be acceptable. This plan was
obviously overtaken by events as the intervention was
implemented well after the microbicide trial had been
concluded. The reason why it had been decided that the
intervention would be disseminated to the women in the
non-intervention arm in the first place was aimed at en-
suring that those women also benefitted directly from
the intervention. Tracking of the women for the inter-
vention phase had also proven difficult. It was therefore
agreed that the findings from this study would be disse-
minated at the two sites so that the principal investiga-
tors could utilise the findings in other and future trials,
if they wished. The dissemination of the intervention to
the 18 women in the non-intervention arm would not
however not serve a critical purpose because the micro-
bicide trial had already closed. More importantly how-
ever, the 18 women in the non-intervention arm
benefited from a session on cervical cancer that was
conducted as part of the non-intervention package.
Plans are in place for the researcher to disseminate the
findings at the two sites in Malawi as well as to conduct
a larger study. The dissemination of findings on the use-
fulness of the intervention to the 36 women would have
been a good opportunity to document their views on the
acceptability and challenges related to the intervention.
It is important to highlight the possibility of some
confounding biases. Time is an important factor in any
study which looks at a particular phenomenon over
time. With time, individuals learn more about research
and about the products being studied. With more his-
tory and exposure, it means they are in a better pos-
ition to give the correct answers when asked questions
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study and intervention study covered similar questions.
It is therefore possible that the bias of maturation
could have been real. It is however important to note
that there was a time lag of more than 8 months be-
tween the first assessment and the second assessment.
This time lag could have weakened the bias caused by
instrument maturity. In any case the maturation would
have affected the intervention and non-intervention
groups equally.
Results from the microbicide study were disseminated
to all participants around March 2009. The first assess-
ment had been conducted between September and No-
vember 2008. The intervention was introduced and
evaluated in July 2009, more than three months after the
dissemination of the microbicide study findings. It is
therefore possible that the dissemination of findings
could have significantly affected the impact of the inter-
vention on understanding. It is important to note, how-
ever, that this would have applied equally to both the
intervention arm and the non-intervention arm. The
women in the two groups were all familiar with the re-
search procedures under study. It can be concluded that
the differences between the intervention and non-
intervention arms were attributable to the intervention.
Conclusions
An intervention developed and implemented as part of
this study showed positive findings. Evaluation of the
intervention suggests that it was useful in improving
understanding of the key concepts (randomisation,
double-blinding, placebo use, and personal implications
of these) under study. More importantly, the study has
shown that, if information on scientific procedures is
provided in a meaningful, structured, locally relevant
and complete way, it is possible to facilitate adequate
understanding. The intervention which was tested
through this study may guide future researchers in
implementing more effective measures to maximise par-
ticipants’ understanding of essential clinical trial proce-
dures. More importantly, the evidence from the
intervention is encouraging as it serves as empirical
proof that understanding can be improved if researchers
use accessible language and examples that demystify re-
search, and present research as a process which is aimed
at improving health care decisions and tools. While the
intervention was tested among real trial participants, it
is possible that there were several confounding variables
that could not be controlled. There is however need to
further test this intervention in an active clinical trial
setting using participants that are in the process of con-
sidering participation in a real trial in order to test im-
pact on both short-term recall and long-term memory.
Testing the intervention using participants that areconsidering trial participation may also assist in answer-
ing the question whether improving understanding may
affect willingness to participate in a trial.
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